PF-07038124 is a topical phosphodiesterase 4 (PDE4) inhibitor developed for the treatment of inflammatory skin diseases such as atopic dermatitis and psoriasis; it offers a potential combination therapy option with biologics like anti-IL-4 and anti-IL-13 antibodies.